Skip to main content
SpringerLink
Log in

Revising the link between proton-pump inhibitors and risk of acute myocardial infarction—a case-crossover analysis

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study is to investigate if the prescription of proton-pump inhibitors (PPIs) was associated with a sudden risk of acute myocardial infarction (AMI) while controlling for time-invariant confounding by using a case-crossover design. An association might indicate that physicians take prodromal symptoms of myocardial ischaemia for dyspepsia.

Methods

We applied a case-crossover design to investigate all AMI patients admitted to the hospital in the Skåne region, Sweden, between Oct 14, 2005 and Dec 31, 2006 and their PPI prescriptions and dispensations 3 months prior to the AMI onset. We retrieved the information about prescribed medication from the Swedish Drug Register containing individual information on all dispensed drugs prescribed in the outpatient care and dispensed in any of the Swedish pharmacies. Additionally, we stratified the analyses by history of AMI.

Results

We identified 3490 AMI cases aged 40 to 90; 61 % were men. The odds ratio for AMI onset in those with a prescription of PPIs during a hazard period of 3 days compared to control periods was 1.36 (95 % confidence interval (CI) 0.82–2.25) in the whole study cohort and 1.66 (95 % CI 1.00–2.76) in those without history of AMI. The corresponding odds ratio (OR) based on the dispensation date (suggesting use of the drug) was 1.26 (95 % CI 0.92–1.72) and 1.29 (95 % CI 0.92–1.83), respectively.

Conclusions

In our opinion, the previously reported increase in risk of adverse cardiac events in patients using PPIs may reflect the fact that an AMI may be misinterpreted as dyspepsia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ho PM, Maddox TM, Wang L, Fihn SD, Jesse RL, Peterson ED, Rumsfeld JS (2009) Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA J Am Med Assoc 301(9):937–944. doi:10.1001/jama.2009.261

    Article  CAS  Google Scholar 

  2. Charlot M, Ahlehoff O, Norgaard ML, Jorgensen CH, Sorensen R, Abildstrom SZ, Hansen PR, Madsen JK, Kober L, Torp-Pedersen C, Gislason G (2010) Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study. Ann Intern Med 153(6):378–386. doi:10.7326/0003-4819-153-6-201009210-00005

    Article  PubMed  Google Scholar 

  3. Charlot M, Grove EL, Hansen PR, Olesen JB, Ahlehoff O, Selmer C, Lindhardsen J, Madsen JK, Kober L, Torp-Pedersen C, Gislason GH (2011) Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study. BMJ (Clin Res Ed) 342:d2690. doi:10.1136/bmj.d2690

    Article  Google Scholar 

  4. O’Donoghue ML, Braunwald E, Antman EM, Murphy SA, Bates ER, Rozenman Y, Michelson AD, Hautvast RW, Ver Lee PN, Close SL, Shen L, Mega JL, Sabatine MS, Wiviott SD (2009) Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet 374(9694):989–997. doi:10.1016/s0140-6736(09)61525-7

    Article  PubMed  Google Scholar 

  5. Bhatt DL, Cryer BL, Contant CF, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Scirica BM, Murphy SA, Cannon CP (2010) Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 363(20):1909–1917. doi:10.1056/NEJMoa1007964

    Article  CAS  PubMed  Google Scholar 

  6. Ghebremariam YT, LePendu P, Lee JC, Erlanson DA, Slaviero A, Shah NH, Leiper J, Cooke JP (2013) An unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor ADMA. Circulation. doi:10.1161/circulationaha.113.003602

    PubMed Central  PubMed  Google Scholar 

  7. Schmidt M, Johansen MB, Robertson DJ, Maeng M, Kaltoft A, Jensen LO, Tilsted HH, Botker HE, Sorensen HT, Baron JA (2012) Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation. Aliment Pharmacol Ther 35(1):165–174. doi:10.1111/j.1365-2036.2011.04890.x

    Article  CAS  PubMed  Google Scholar 

  8. Juurlink DN, Dormuth CR, Huang A, Hellings C, Paterson JM, Raymond C, Kozyrskyj A, Moride Y, Macdonald EM, Mamdani MM (2013) Proton pump inhibitors and the risk of adverse cardiac events. PLoS One 8(12):e84890. doi:10.1371/journal.pone.0084890

    Article  PubMed Central  PubMed  Google Scholar 

  9. Blackburn DF, Lamb DA, McLeod MM, Eurich DT (2010) Increased use of acid-suppressing drugs before the occurrence of ischemic events: a potential source of confounding in recent observational studies. Pharmacotherapy 30(10):985–993. doi:10.1592/phco.30.10.985

    Article  PubMed  Google Scholar 

  10. Edmundowicz S (2002) 20 common problems in gastroenterology. McGraw-Hill Companies, United States

    Google Scholar 

  11. Bruyninckx R, Aertgeerts B, Bruyninckx P, Buntinx F (2008) Signs and symptoms in diagnosing acute myocardial infarction and acute coronary syndrome: a diagnostic meta-analysis. Br J Gen Pract J R Coll Gen Pract 58(547):105–111. doi:10.3399/bjgp08X277014

    Google Scholar 

  12. Piessevaux H, De Winter B, Louis E, Muls V, De Looze D, Pelckmans P, Deltenre M, Urbain D, Tack J (2009) Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc 21(4):378–388. doi:10.1111/j.1365-2982.2009.01262.x

    Article  CAS  Google Scholar 

  13. Phillips RL Jr, Bartholomew LA, Dovey SM, Fryer GE Jr, Miyoshi TJ, Green LA (2004) Learning from malpractice claims about negligent, adverse events in primary care in the United States. Qual Saf Health Care 13(2):121–126

    Article  PubMed Central  PubMed  Google Scholar 

  14. Bird S (2005) Acute myocardial infarction: medicolegal issues. Aust Fam Physician 34(6):489–490

    PubMed  Google Scholar 

  15. Kostopoulou O, Delaney BC, Munro CW (2008) Diagnostic difficulty and error in primary care—a systematic review. Fam Pract 25(6):400–413. doi:10.1093/fampra/cmn071

    Article  PubMed  Google Scholar 

  16. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50(7):e1–e157. doi:10.1016/j.jacc.2007.02.013

    Article  PubMed  Google Scholar 

  17. Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM (2008) ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 118(18):1894–1909. doi:10.1161/circulationaha.108.191087

    Article  PubMed  Google Scholar 

  18. Quinn MJ, Fitzgerald DJ (1999) Ticlopidine and clopidogrel. Circulation 100(15):1667–1672. doi:10.1161/01.cir.100.15.1667

    Article  CAS  PubMed  Google Scholar 

  19. Delaney JA, Suissa S (2009) The case-crossover study design in pharmacoepidemiology. Stat Methods Med Res 18(1):53–65. doi:10.1177/0962280208092346

    Article  PubMed  Google Scholar 

  20. Maclure M, Mittleman MA (2000) Should we use a case-crossover design? Annu Rev Public Health 21:193–221. doi:10.1146/annurev.publhealth.21.1.193

    Article  CAS  PubMed  Google Scholar 

  21. Etienney I, Beaugerie L, Viboud C, Flahault A (2003) Non-steroidal anti-inflammatory drugs as a risk factor for acute diarrhoea: a case crossover study. Gut 52(2):260–263

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Geltman EM, Ehsani AA, Campbell MK, Schechtman K, Roberts R, Sobel BE (1979) The influence of location and extent of myocardial infarction on long-term ventricular dysrhythmia and mortality. Circulation 60(4):805–814

    Article  CAS  PubMed  Google Scholar 

  23. Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, Henry DA, Kopp A, Mamdani MM (2009) A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ Can Med Assoc J J Assoc Med Can 180(7):713–718. doi:10.1503/cmaj.082001

    Article  Google Scholar 

  24. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, Freij A, Thorsen M (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361(11):1045–1057. doi:10.1056/NEJMoa0904327

    Article  CAS  PubMed  Google Scholar 

  25. Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundstrom A, Westerholm B, Rosen M (2007) The new Swedish Prescribed Drug Register—opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16(7):726–735. doi:10.1002/pds.1294

    Article  PubMed  Google Scholar 

  26. Merlo J, Lindblad U, Pessah-Rasmussen H, Hedblad B, Rastam J, Isacsson SO, Janzon L, Rastam L (2000) Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers. Eur J Epidemiol 16(3):235–243

    Article  CAS  PubMed  Google Scholar 

  27. Hammar N, Alfredsson L, Rosen M, Spetz CL, Kahan T, Ysberg AS (2001) A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden. Int J Epidemiol 30(Suppl 1):S30–S34

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Swedish Research Council (VR) (nr. #2013-2484, JM) and the Epidemiology and Register Centre South (AT).

Conflict of interest

The authors declare no conflict of interests.

Author contributions

The conception and design of the article were provided by JM, AT and HO; the acquisition of data by JM; the analysis of data by AT, RPV, HO and JM; the interpretation of data by AT, RPV, JM, HO and PT; and the article draft by AT and JM. All authors contributed to the critical revision of the article for important intellectual content and approval of the final version.

Author information

Authors and Affiliations

  1. Social Epidemiology, Department of Clinical Sciences, Faculty of Medicine, Lund University, Malmö, Sweden

    Aleksandra Turkiewicz, Raquel Perez Vicente & Juan Merlo

  2. Orthopaedics, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden

    Aleksandra Turkiewicz

  3. Department of Clinical Sciences, Faculty of Medicine, Lund University, Malmö, Sweden

    Henrik Ohlsson

  4. Cardiovascular Epidemiology, Faculty of Medicine, Lund University, Malmö, Sweden

    Patrik Tyden

Authors
  1. Aleksandra Turkiewicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Raquel Perez Vicente
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Henrik Ohlsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Patrik Tyden
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Juan Merlo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aleksandra Turkiewicz.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Turkiewicz, A., Vicente, R.P., Ohlsson, H. et al. Revising the link between proton-pump inhibitors and risk of acute myocardial infarction—a case-crossover analysis. Eur J Clin Pharmacol 71, 125–129 (2015). https://doi.org/10.1007/s00228-014-1779-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-014-1779-6

Keywords

Search

Navigation